CLINICAL_TRIALS
trial_result
· 2014-09-26
Clinical Trial Update: Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Summary
Phase 2 trial evaluating BIIL 284 BS in patients with chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED